Australian Clinical Labs
ACL.AX
#6988
Rank
โ‚น36.86 B
Marketcap
โ‚น183.76
Share price
-1.43%
Change (1 day)
15.73%
Change (1 year)

Revenue for Australian Clinical Labs (ACL.AX)

Revenue in 2023: โ‚น39.07 Billion

According to Australian Clinical Labs's latest financial reports the company's current revenue (TTM ) is โ‚น39.07 Billion. In 2023 the company made a revenue of โ‚น39.07 Billion a decrease over the revenue in the year 2022 that were of โ‚น58.04 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Australian Clinical Labs from 2021 to 2023

Annual revenue

Year Revenue Change
2023โ‚น39.07 B-32.69%
2022โ‚น58.04 B41.26%
2021โ‚น41.09 B